President Trump is expected to announce a proposal on Thursday aimed at expanding access to in vitro fertilization, marking the administration’s first formal action on the issue, The New York Times’ Caroline Kitchener and Tyler Pager report. The plan will outline an employer benefit option encouraging companies to offer IVF and infertility coverage alongside standard benefits like vision or dental, though participation will be voluntary and no federal subsidies are planned. Shares of Progyny (PGNY), which provides comprehensive coverage for preconception, fertility, adoption and surrogacy, are up nearly 7% to $21.67 in afternoon trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
